| Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study R Aggarwal, J Huang, JJ Alumkal, L Zhang, FY Feng, GV Thomas, ... Journal of Clinical Oncology 36 (24), 2492-2503, 2018 | 659 | 2018 |
| Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance JJ Alumkal, D Sun, E Lu, TM Beer, GV Thomas, E Latour, R Aggarwal, ... Proceedings of the National Academy of Sciences 117 (22), 12315-12323, 2020 | 112 | 2020 |
| Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway J Carrot-Zhang, X Yao, S Devarakonda, A Deshpande, JS Damrauer, ... Cell reports 34 (5), 2021 | 31 | 2021 |
| Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer R Aggarwal, GR Romero, V Friedl, A Weinstein, A Foye, J Huang, F Feng, ... Prostate cancer and prostatic diseases 24 (1), 81-87, 2021 | 18 | 2021 |
| PLATYPUS: A multiple—view learning predictive framework for cancer drug sensitivity prediction K Graim, V Friedl, KE Houlahan, JM Stuart Biocomputing 2019: Proceedings of the pacific symposium, 136-147, 2018 | 18 | 2018 |
| Epigenomic blood-based early detection of pancreatic cancer employing cell-free DNA D Haan, A Bergamaschi, V Friedl, GD Guler, Y Ning, R Reggiardo, ... Clinical Gastroenterology and Hepatology 21 (7), 1802-1809. e6, 2023 | 9 | 2023 |
| Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer DH Kwon, L Zhang, DA Quigley, A Foye, WS Chen, CK Wong, FY Feng, ... Urologic Oncology: Seminars and Original Investigations 38 (12), 931. e9-931 …, 2020 | 8 | 2020 |
| Using transcriptional signatures to find cancer drivers with LURE D Haan, R Tao, V Friedl, IN Anastopoulos, CK Wong, AS Weinstein, ... PACIFIC SYMPOSIUM ON BIOCOMPUTING 2020, 343-354, 2019 | 7 | 2019 |
| Contributions from the 2019 literature on bioinformatics and translational informatics M Smaïl-Tabbone, B Rance Yearbook of Medical Informatics 29 (01), 188-192, 2020 | 4 | 2020 |
| Intermediate atypical carcinoma (IAC): A discrete subtype of metastatic castration-resistant prostate cancer (mCRPC) suggesting that treatment-associated small cell … EJ Small, RR Aggarwal, V Friedl, A Weinstein, GV Thomas, LD True, ... Journal of Clinical Oncology 38 (6_suppl), 158-158, 2020 | 3 | 2020 |
| Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Using Cell-Free DNA 5-Hydroxymethylation Signatures D Haan, A Bergamaschi, GD Guler, V Friedl, Y Ning, R Reggiardo, ... MedRxiv, 2021.12. 27.21268450, 2021 | 2 | 2021 |
| 69MO 5-Hydroxymethycytosine analysis reveals stable epigenetic changes in tumor tissue that enable cfDNA cancer predictions F Feng, Y Ning, Y Xue, V Friedl, D Hann, B Gibb, A Bergamaschi, G Guler, ... Annals of Oncology 33, S573, 2022 | 1 | 2022 |
| Analytical Validation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation Signatures S Chowdhury, M Kesling, M Collins, V Lopez, Y Xue, G Oliveira, V Friedl, ... The Journal of Molecular Diagnostics, 2024 | | 2024 |
| Single-cell signatures identify microenvironment factors in tumors associated with patient outcomes Y Xue, V Friedl, H Ding, CK Wong, JM Stuart Cell Reports Methods 4 (6), 2024 | | 2024 |
| Tu1439 DETECTION OF HIGH-RISK PANCREATIC CYSTS USING AVANTECTTM BLOOD-BASED TEST A Bergamaschi, A Leighton, D Haan, V Friedl, V Lopez, M Peters, ... Gastroenterology 166 (5), S-1341-S-1342, 2024 | | 2024 |
| Leveraging compact feature sets for TCGA-based molecular subtype classification on new samples K Ellrott, CK Wong, C Yau, MA Castro, J Lee, B Karlberg, JK Grewal, ... Cancer Research 84 (6_Supplement), 6548-6548, 2024 | | 2024 |
| Abstract A010: Evaluation of the Avantect Pancreatic Cancer Test for identifying high-risk pancreatic cysts A Bergamaschi, D Haan, V Friedl, G Guler, M Kesling, M Collins, K Hazen, ... Cancer Research 84 (2_Supplement), A010-A010, 2024 | | 2024 |
| 135. Tumor deconvolution using comprehensive single-cell RNA sequencing cell type signatures YB Xue, V Friedl Cancer Genetics 268, 43, 2022 | | 2022 |
| Clinical and molecular features of low prostate-specific membrane antigen (PSMA) expression in patients (pts) with metastatic castration resistant prostate cancer (mCRPC). I de Kouchkovsky, L Zhang, J Huang, K Trepka, J Chou, A Foye, D Shui, ... Journal of Clinical Oncology 40 (6_suppl), 167-167, 2022 | | 2022 |
| Transcriptional Signatures of the Tumor and the Tumor Microenvironment Predict Cancer Patient Outcomes V Friedl University of California, Santa Cruz, 2021 | | 2021 |
Alana S. WeinsteinUniversity of California在 ucsc.edu 的电子邮件经过验证
